ASAHI KASEI CORPORATE VENTURE CAPITAL
Asahi Kasei Corporate Venture Capital is an investment firm that focused on primary sectors of homes, materials, and healthcare. The firm is focused on investing in innovative global firms in areas of strategic importance to Asahi Kasei. The company mission to create new long-term business opportunities for Asahi Kasei. Asahi Kasei Corporate Venture Capital was founded in 2008 and is based in Tokyo with offices in Menlo Park and Boston Area.
ASAHI KASEI CORPORATE VENTURE CAPITAL
Industry:
Advanced Materials Electronics Health Care Pharmaceutical
Founded:
2008-01-01
Status:
Active
Contact:
650.853.1900
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Nginx JQuery CDN Corporation Schema
Similar Organizations
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-16 | Swing Therapeutics | Asahi Kasei Corporate Venture Capital investment in Series A - Swing Therapeutics | 10.3 M USD |
| 2022-02-03 | Koya Medical | Asahi Kasei Corporate Venture Capital investment in Series B - Koya Medical | 26 M USD |
| 2021-05-06 | Aerobiotix | Asahi Kasei Corporate Venture Capital investment in Venture Round - Aerobiotix | 25 M USD |
| 2021-04-13 | Hazel Technologies | Asahi Kasei Corporate Venture Capital investment in Series C - Hazel Technologies | 70 M USD |
| 2021-03-24 | Firework | Asahi Kasei Corporate Venture Capital investment in Series A - Firework | 55 M USD |
| 2019-08-12 | Hazel Technologies | Asahi Kasei Corporate Venture Capital investment in Series B - Hazel Technologies | 13 M USD |
| 2018-09-18 | Feldan Therapeutics | Asahi Kasei Corporate Venture Capital investment in Series A - Feldan Therapeutics | 13.8 M USD |